Randomized, Placebo-Controlled, Phase III Trial of Yeast-Derived Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Versus Peptide Vaccination Versus GM-CSF Plus Peptide Vaccination Versus Placebo in Patients With No Evidence of Disease After Complete Surgical Resection of Locally Advanced and/or Stage IV Melanoma: A Trial of the Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group (E4697)

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
David H LawsonJ M Kirkwood

Abstract

We conducted a double-blind, placebo-controlled trial to evaluate the effect of granulocyte-macrophage colony-stimulating factor (GM-CSF) and peptide vaccination (PV) on relapse-free survival (RFS) and overall survival (OS) in patients with resected high-risk melanoma. Patients with completely resected stage IV or high-risk stage III melanoma were grouped by human leukocyte antigen (HLA) -A2 status. HLA-A2-positive patients were randomly assigned to receive GM-CSF, PV, both, or placebo; HLA-A2-negative patients, GM-CSF or placebo. Treatment lasted for 1 year or until recurrence. Efficacy analyses were conducted in the intent-to-treat population. A total of 815 patients were enrolled. There were no significant improvements in OS (stratified log-rank P = .528; hazard ratio, 0.94; 95% repeated CI, 0.77 to 1.15) or RFS (P = .131; hazard ratio, 0.88; 95% CI, 0.74 to 1.04) in the patients assigned to GM-CSF (n = 408) versus those assigned to placebo (n = 407). The median OS times with GM-CSF versus placebo treatments were 69.6 months (95% CI, 53.4 to 83.5 months) versus 59.3 months (95% CI, 44.4 to 77.3 months); the 5-year OS probability rates were 52.3% (95% CI, 47.3% to 57.1%) versus 49.4% (95% CI, 44.3% to 54.3%), respectively. Th...Continue Reading

References

Jun 11, 1999·Advances in Immunology·D BellJ Banchereau
Apr 14, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D Lawson, J M Kirkwood
Apr 14, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·L E SpitlerS J Soong
Jul 2, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Adil I DaudDmitry Gabrilovich
Feb 23, 2013·American Journal of Clinical Oncology·Travis E GrotzJames W Jakub
Nov 5, 2014·JAMA : the Journal of the American Medical Association·F Stephen HodiJohn M Kirkwood

❮ Previous
Next ❯

Citations

Jul 4, 2016·Cancer Immunology, Immunotherapy : CII·Christoph HoellerChristian U Blank
Nov 21, 2007·Surgical Oncology Clinics of North America·Nicole M AgostinoPaul J Mosca
Sep 18, 2002·Mayo Clinic Proceedings·Stephan D ThoméMichael P Heldebrant
Nov 16, 2010·Seminars in Oncology·Alexander M M EggermontCaroline Robert
Dec 21, 2016·Immunotherapy·Satoshi WadaTetsuro Sasada
Nov 4, 2016·Human Vaccines & Immunotherapeutics·Robert O Dillman
Jan 14, 2017·Medicinal Research Reviews·Sergey O BachurinAleksey A Ustyugov
Mar 18, 2017·Immunotherapy·Wan-Lun YanShih-Jen Liu
Feb 7, 2018·The Cochrane Database of Systematic Reviews·Sandro PasqualiSimone Mocellin
Jul 30, 2017·Immunology·Eva Bräunlein, Angela M Krackhardt
Sep 1, 2017·Human Vaccines & Immunotherapeutics·Margaret E Gatti-MaysMarijo Bilusic
Jun 7, 2018·Oncoimmunology·Elena García-MartínezLorenzo Galluzzi
Aug 29, 2018·Immunotherapy·Emily Feld, Tara C Mitchell
Jan 23, 2019·FEMS Yeast Research·Ravinder Kumar, Piyush Kumar
Jun 2, 2016·American Society of Clinical Oncology Educational Book·Alexander C J van AkkooiPaul Lorigan
Dec 28, 2019·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ahmad A TarhiniJohn M Kirkwood
Sep 9, 2016·JAMA Facial Plastic Surgery·Joseph ZengaShaun C Desai
Aug 21, 2019·Journal of Leukocyte Biology·Daniel ShaeJohn Tanner Wilson
Apr 15, 2020·Toxins·Robert D CarlsonAdam E Snook
Sep 15, 2020·Melanoma Management·Robert O Dillman
Dec 1, 2016·Melanoma Management·Robert O DillmanAndrew N Cornforth
May 19, 2017·Journal for Immunotherapy of Cancer·Sacha GnjaticLisa H Butterfield
Feb 17, 2019·International Journal of Molecular Sciences·Francesco BorrielloGianni Marone
Jun 1, 2016·Melanoma Management·Eytan Ben-Ami, Jacob Schachter
Dec 14, 2018·Oncoimmunology·Lucillia BezuLorenzo Galluzzi
May 21, 2020·International Journal of Molecular Sciences·Nico M SieversNiels Schaft
May 26, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Lisa H ButterfieldDavid H Lawson
Jan 30, 2021·Targeted Oncology·Michael A MorseDuane A Mitchell
Oct 31, 2020·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jessica JouEzra E W Cohen
Mar 9, 2021·Frontiers in Immunology·Stefania CuzzubboStephanie E B McArdle
May 31, 2020·Cancer Treatment Reviews·Tara D BaetzTeresa M Petrella
Mar 24, 2021·Cell Proliferation·Wensi LiuJianping Li

❮ Previous
Next ❯

Related Concepts

Related Feeds

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.

Related Papers

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Lynn E SpitlerS J Soong
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Karen KellyFrances A Shepherd
© 2021 Meta ULC. All rights reserved